Clinical Chemistry And Pathologic Of Biochemistry (CCPB) Practice Test

When evaluating hypercalcemia, the first key test is the parathyroid hormone level. In the presence of high calcium, PTH should be suppressed. If PTH is elevated or remains inappropriately normal (not suppressed) despite hypercalcemia, the parathyroid gland is driving the process. This points to PTH-dependent causes such as primary hyperparathyroidism (and related states where PTH remains active despite high calcium). If the PTH level is suppressed, the hypercalcemia is more likely due to PTH-independent mechanisms, such as malignancy-associated hypercalcemia (PTHrP), vitamin D–mediated processes, or granulomatous disease, where calcium is elevated through non-PTH pathways. Thus, an elevated or inappropriately normal PTH with hypercalcemia best indicates PTH-dependent etiologies, whereas suppressed PTH points to PTH-independent causes.